Agilent Technologies Inc.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Oct 31, 2025 · FY), Agilent Technologies Inc. reported revenue of $6.9B (+6.7% year on year) and net income of $1.3B (+1.1% year on year).
| Line item | Oct 31, 2025 · FY | Oct 31, 2024 · FY | Oct 31, 2023 · FY | Oct 31, 2022 · FY |
|---|---|---|---|---|
| Net revenue | $6.9B | $6.5B | $6.8B | $6.8B |
| Cost of revenue | $3.3B | $3.0B | $3.4B | $3.1B |
| Research and development | $455.0M | $479.0M | $481.0M | $467.0M |
| Selling, general and administrative | $1.7B | $1.6B | $1.6B | $1.6B |
| Total costs and expenses | $5.5B | $5.0B | $5.5B | $5.2B |
| Income from operations | $1.5B | $1.5B | $1.4B | $1.6B |
| Interest income | $62.0M | $80.0M | $51.0M | $9.0M |
| Interest expense | ($112.0M) | ($96.0M) | ($95.0M) | ($84.0M) |
| Other income (expense), net | $6.0M | $49.0M | $33.0M | ($39.0M) |
| Income before taxes, as reported | $1.4B | $1.5B | $1.3B | $1.5B |
| Provision for income taxes | $132.0M | $232.0M | $99.0M | $250.0M |
| Net Income | $1.3B | $1.3B | $1.2B | $1.3B |
| Net income per share - basic | $4.59 | $4.44 | $4.22 | $4.19 |
| Net income per share - diluted | $4.57 | $4.43 | $4.19 | $4.18 |
| Basic (in shares) | 284.0M | 290.0M | 294.0M | 299.0M |
| Diluted (in shares) | 285.0M | 291.0M | 296.0M | 300.0M |
| Line item | Jul 31, 2026 · Q3 | Apr 30, 2026 · Q2 | Jan 31, 2026 · Q1 | Jul 31, 2025 · Q3 |
|---|---|---|---|---|
| Net revenue | $1.9B | $1.8B | $1.8B | $1.7B |
| Cost of revenue | $836.0M | $845.0M | $852.0M | $850.0M |
| Research and development | $123.0M | $126.0M | $117.0M | $111.0M |
| Selling, general and administrative | $475.0M | $465.0M | $476.0M | $417.0M |
| Total costs and expenses | $1.4B | $1.4B | $1.4B | $1.4B |
| Income from operations | $444.0M | $399.0M | $353.0M | $360.0M |
| Interest income | $15.0M | $13.0M | $15.0M | $16.0M |
| Interest expense | ($29.0M) | ($25.0M) | ($25.0M) | ($28.0M) |
| Other income (expense), net | $14.0M | $21.0M | $21.0M | $18.0M |
| Income before taxes | $444.0M | $408.0M | $364.0M | $366.0M |
| Provision for income taxes | $82.0M | $69.0M | $59.0M | $30.0M |
| Net income | $362.0M | $339.0M | $305.0M | $336.0M |
| Basic | $1.28 | $1.20 | $1.08 | $1.18 |
| Diluted | $1.28 | $1.20 | $1.07 | $1.18 |
| Basic | 282.0M | 282.0M | 283.0M | 284.0M |
| Diluted | 283.0M | 283.0M | 284.0M | 285.0M |
| Line item | Oct 31, 2025 · FY | Oct 31, 2024 · FY | Oct 31, 2023 · FY | Oct 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $1.8B | $1.3B | $1.6B | $1.1B |
| Accounts receivable, net | $1.5B | $1.3B | $1.3B | $1.4B |
| Inventory | $1.0B | $972.0M | $1.0B | $1.0B |
| Other current assets | $293.0M | $334.0M | $274.0M | $282.0M |
| Total current assets | $4.6B | $4.0B | $4.2B | $3.8B |
| Property, plant and equipment, net | $2.0B | $1.8B | $1.3B | $1.1B |
| Goodwill | $4.5B | $4.5B | $4.0B | $4.0B |
| Other intangible assets, net | $445.0M | $547.0M | $475.0M | $821.0M |
| Long-term investments | $133.0M | $175.0M | $164.0M | $195.0M |
| Other assets | $1.1B | $910.0M | $708.0M | $686.0M |
| Total assets | $12.7B | $11.8B | $10.8B | $10.5B |
| Accounts payable | $570.0M | $540.0M | $418.0M | $580.0M |
| Employee compensation and benefits | $443.0M | $368.0M | $371.0M | $455.0M |
| Deferred revenue | $624.0M | $544.0M | $505.0M | $461.0M |
| Short-term debt | $304.0M | $45.0M | $0 | $36.0M |
| Other accrued liabilities | $406.0M | $398.0M | $309.0M | $329.0M |
| Total current liabilities | $2.3B | $1.9B | $1.6B | $1.9B |
| Long-Term Debt | $3.0B | $3.3B | $2.7B | $2.7B |
| Retirement and post-retirement benefits | $126.0M | $130.0M | $103.0M | $97.0M |
| Other long-term liabilities | $463.0M | $578.0M | $477.0M | $536.0M |
| Total liabilities | $6.0B | $5.9B | $4.9B | $5.2B |
| Preferred stock; $0.01 par value; 125,000,000 shares authorized; none issued and outstanding | 0 | 0 | 0 | 0 |
| Common stock; $0.01 par value; 2,000,000,000 shares authorized; 283,054,377 shares at October 31, 2025 and 285,193,011 shares at October 31, 2024 issued and outstanding | 3.0M | 3.0M | 3.0M | 3.0M |
| Additional paid-in-capital | $5.6B | $5.5B | $5.4B | $5.3B |
| Retained earnings | $1.4B | $750.0M | $782.0M | $324.0M |
| Accumulated other comprehensive loss | ($226.0M) | ($305.0M) | ($327.0M) | ($347.0M) |
| Total stockholders' equity | $6.7B | $5.9B | $5.8B | $5.3B |
| Total liabilities and stockholders' equity | $12.7B | $11.8B | $10.8B | $10.5B |
| Line item | Jul 31, 2026 | Apr 30, 2026 | Jan 31, 2026 | Jul 31, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $1.8B | $1.8B | $1.8B | $1.5B |
| Accounts receivable, net | $1.5B | $1.5B | $1.5B | $1.4B |
| Inventory | $1.1B | $1.1B | $1.1B | $1.0B |
| Other current assets | $340.0M | $369.0M | $277.0M | $322.0M |
| Total current assets | $4.7B | $4.8B | $4.6B | $4.3B |
| Property, plant and equipment, net | $2.1B | $2.1B | $2.1B | $2.0B |
| Goodwill | $5.0B | $4.5B | $4.5B | $4.5B |
| Other intangible assets, net | $906.0M | $407.0M | $426.0M | $469.0M |
| Long-term investments | $130.0M | $136.0M | $135.0M | $133.0M |
| Other assets | $1.1B | $1.2B | $1.1B | $930.0M |
| Total assets | $14.0B | $13.1B | $12.8B | $12.2B |
| Accounts payable | $608.0M | $615.0M | $602.0M | $530.0M |
| Employee compensation and benefits | $423.0M | $387.0M | $297.0M | $346.0M |
| Deferred revenue | $640.0M | $665.0M | $682.0M | $620.0M |
| Short-term debt | $304.0M | $304.0M | $304.0M | $59.0M |
| Other accrued liabilities | $314.0M | $298.0M | $349.0M | $337.0M |
| Total current liabilities | $2.3B | $2.3B | $2.2B | $1.9B |
| Long-term debt | $3.6B | $3.1B | $3.0B | $3.4B |
| Retirement and post-retirement benefits | $128.0M | $127.0M | $130.0M | $119.0M |
| Other long-term liabilities | $542.0M | $496.0M | $491.0M | $495.0M |
| Total liabilities | $6.6B | $5.9B | $5.9B | $5.9B |
| Preferred stock; $0.01 par value; 125,000,000 shares authorized; none issued and outstanding at July 31, 2026 and October 31, 2025 | 0 | 0 | 0 | 0 |
| Common stock; $0.01 par value; 2,000,000,000 shares authorized; 281,965,813 shares at July 31, 2026 and 283,054,377 shares at October 31, 2025, issued and outstanding | 3.0M | 3.0M | 3.0M | 3.0M |
| Additional paid-in-capital | $5.7B | $5.6B | $5.6B | $5.5B |
| Retained earnings | $1.9B | $1.7B | $1.5B | $1.1B |
| Accumulated other comprehensive loss | ($233.0M) | ($202.0M) | ($184.0M) | ($283.0M) |
| Total stockholders' equity | $7.4B | $7.1B | $6.9B | $6.4B |
| Total liabilities and stockholders' equity | $14.0B | $13.1B | $12.8B | $12.2B |
| Line item | Oct 31, 2025 · FY | Oct 31, 2024 · FY | Oct 31, 2023 · FY | Oct 31, 2022 · FY |
|---|---|---|---|---|
| Net Income | $1.3B | $1.3B | $1.2B | $1.3B |
| Depreciation and amortization | $288.0M | $257.0M | $271.0M | $317.0M |
| Share-based compensation | $128.0M | $129.0M | $111.0M | $125.0M |
| Deferred taxes expense (benefit) | ($130.0M) | ($64.0M) | ($56.0M) | $8.0M |
| Excess and obsolete inventory related charges | $45.0M | $45.0M | $40.0M | $24.0M |
| Net gain (loss) on equity securities | ($36.0M) | $6.0M | ($41.0M) | ($67.0M) |
| Asset impairment charges | $15.0M | $19.0M | $277.0M | $0 |
| Change in fair value of contingent consideration | $0 | $0 | $1.0M | ($25.0M) |
| Net gain on Divestiture of Business | $0 | $0 | $43.0M | — |
| Other non-cash expense, net | $5.0M | ($1.0M) | $6.0M | $11.0M |
| Accounts receivable, net | ($149.0M) | $7.0M | $132.0M | ($321.0M) |
| Inventory | ($97.0M) | $34.0M | ($33.0M) | ($248.0M) |
| Accounts payable | $16.0M | $103.0M | ($171.0M) | $121.0M |
| Employee compensation and benefits | $69.0M | ($12.0M) | ($91.0M) | ($22.0M) |
| Other assets and liabilities | $30.0M | ($49.0M) | $47.0M | ($8.0M) |
| Net cash provided by operating activities | $1.6B | $1.8B | $1.8B | $1.3B |
| Payments to acquire property, plant and equipment | ($407.0M) | ($378.0M) | ($298.0M) | ($291.0M) |
| Proceeds from the sale of equity securities | $8.0M | $0 | $5.0M | $22.0M |
| Payments to acquire equity securities | $0 | ($5.0M) | ($8.0M) | ($13.0M) |
| Proceeds from convertible note | $2.0M | $0 | $4.0M | — |
| Payment in exchange for convertible note | ($1.0M) | ($13.0M) | ($12.0M) | ($4.0M) |
| Proceeds from Divestiture of Businesses | $0 | $0 | $50.0M | — |
| Acquisitions of businesses and intangible assets, net of cash acquired | $4.0M | ($862.0M) | ($51.0M) | ($52.0M) |
| Net cash used in investing activities | ($394.0M) | ($1.3B) | ($310.0M) | ($338.0M) |
| Proceeds from the issuance of common stock under employee stock plans | 72.0M | 77.0M | 67.0M | 58.0M |
| Payment of taxes related to net share settlement of equity awards | ($29.0M) | ($30.0M) | ($54.0M) | ($67.0M) |
| Payments for repurchase of common stock | ($425.0M) | ($1.1B) | ($575.0M) | ($1.1B) |
| Payment of excise taxes related to repurchases of common stock | ($10.0M) | ($3.0M) | — | — |
| Payment of dividends | ($282.0M) | ($274.0M) | ($265.0M) | ($250.0M) |
| Proceeds from Issuance of Long-Term Debt | $4.0M | $1.2B | $0 | — |
| Repayments of Long-Term Debt | ($3.0M) | ($600.0M) | $0 | — |
| Payments of debt issuance costs | $0 | ($9.0M) | $0 | $0 |
| Net proceeds from (Repayments of ) Short-Term Debt | ($42.0M) | $40.0M | ($35.0M) | — |
| Payment for Contingent Consideration | $0 | $0 | ($68.0M) | — |
| Net cash used in financing activities | ($715.0M) | ($752.0M) | ($930.0M) | ($1.4B) |
| Effect of exchange rate movements | $9.0M | ($2.0M) | $5.0M | ($36.0M) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | $459.0M | ($261.0M) | $537.0M | ($434.0M) |
| Cash, cash equivalents and restricted cash at beginning of year | $1.3B | $1.6B | $1.1B | $1.5B |
| Cash, cash equivalents and restricted cash at end of year | $1.8B | $1.3B | $1.6B | $1.1B |
| Income Taxes Payments, Net of refunds received | $318.0M | $314.0M | $199.0M | $279.0M |
| Interest payments, net of capitalized interest | $101.0M | $80.0M | $89.0M | $85.0M |
| Net change in property, plant and equipment included in accounts payable and accrued liabilities-increase (decrease) | $11.0M | $9.0M | $4.0M | $26.0M |
| Share Repurchase Program, Excise Tax, Payable | $3.0M | $10.0M | — | — |
| Line item | Jul 31, 2026 · YTD | Apr 30, 2026 · YTD | Jan 31, 2026 · Q1 | Jul 31, 2025 · YTD |
|---|---|---|---|---|
| Net income | $1.0B | $644.0M | $305.0M | $869.0M |
| Depreciation and amortization | $200.0M | $134.0M | $67.0M | $217.0M |
| Share-based compensation | $105.0M | $73.0M | $41.0M | $102.0M |
| Deferred taxes expense (benefit) | $77.0M | $57.0M | $25.0M | ($35.0M) |
| Excess and obsolete inventory related charges | $35.0M | $25.0M | $10.0M | $30.0M |
| Net gain (loss) on equity securities | ($2.0M) | $1.0M | $2.0M | ($28.0M) |
| Asset, Impairment Loss | $0 | $0 | — | $15.0M |
| Other non-cash income (expense), net | ($12.0M) | ($4.0M) | ($2.0M) | ($4.0M) |
| Accounts receivable,net | $16.0M | ($6.0M) | ($18.0M) | ($44.0M) |
| Inventory | ($110.0M) | ($85.0M) | ($39.0M) | ($72.0M) |
| Accounts payable | $41.0M | $54.0M | $39.0M | ($13.0M) |
| Employee compensation and benefits | ($25.0M) | ($59.0M) | ($151.0M) | ($26.0M) |
| Other assets and liabilities | ($295.0M) | ($295.0M) | ($11.0M) | ($61.0M) |
| Net cash provided by operating activities | $1.1B | $545.0M | $268.0M | $1.0B |
| Payments to acquire property, plant and equipment | ($249.0M) | ($169.0M) | ($93.0M) | ($314.0M) |
| Proceeds from sale of equity securities | $0 | — | — | $5.0M |
| Proceeds from convertible note | $0 | — | — | $2.0M |
| Payments in exchange for convertible note | ($3.0M) | ($1.0M) | $0 | ($1.0M) |
| Payments to acquire businesses and intangible assets, net of cash acquired | ($950.0M) | $0 | $0 | $4.0M |
| Net cash used in investing activities | ($1.2B) | ($170.0M) | ($93.0M) | ($304.0M) |
| Proceeds from issuance of common stock under employee stock plans | 63.0M | 32.0M | 31.0M | 60.0M |
| Payments of taxes related to net share settlement of equity awards | ($31.0M) | ($29.0M) | ($27.0M) | ($28.0M) |
| Payments for repurchase of common stock | ($295.0M) | ($217.0M) | ($152.0M) | ($340.0M) |
| Payment of excise taxes related to repurchases of common stock | ($3.0M) | ($3.0M) | — | ($10.0M) |
| Payments of dividends | ($216.0M) | ($144.0M) | ($72.0M) | ($212.0M) |
| Proceeds from Issuance of Long-Term Debt | $600.0M | $0 | $0 | $4.0M |
| Repayments of Long-Term Debt | ($4.0M) | ($3.0M) | ($2.0M) | ($2.0M) |
| Payments of Debt Issuance Costs | ($5.0M) | — | — | — |
| Net proceeds from (repayments of) short-term debt | $0 | $0 | $0 | $13.0M |
| Repayment of finance lease | ($4.0M) | ($2.0M) | — | — |
| Net cash provided by (used in) financing activities | $105.0M | ($366.0M) | ($222.0M) | ($515.0M) |
| Effect of Exchange Rate Movements | $2.0M | $9.0M | $16.0M | $10.0M |
| Net increase (decrease) in cash, cash equivalents and restricted cash | ($31.0M) | $18.0M | ($31.0M) | $205.0M |
| Cash, cash equivalents and restricted cash at beginning of period | $1.8B | $1.8B | $1.8B | $1.3B |
| Cash, cash equivalents and restricted cash at end of period | $1.8B | $1.8B | $1.8B | $1.5B |
| Income tax paid, net of refunds received | $376.0M | $320.0M | $105.0M | $304.0M |
| Interest payments, net of capitalized interest | $47.0M | $45.0M | $1.0M | $55.0M |
| Net change in property, plant and equipment included in Accounts Payable and Accrued Liabilities increase (decrease) | ($9.0M) | ($11.0M) | ($11.0M) | — |
| Excise taxes on share repurchases, accrued but not paid | $2.0M | $1.0M | — | $2.0M |
Agilent Technologies Inc. score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.